Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Shares Outstanding (Weighted Average) (2021 - 2025)

Tenon Medical has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $7384.0 for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $7384.0 for Q4 2025, up 508.24% from a year ago — trailing twelve months through Dec 2025 was $7384.0 (up 508.24% YoY), and the annual figure for FY2025 was $7384.0, up 508.24%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $7384.0 at Tenon Medical, down from $8250.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for TNON hit a ceiling of $830000.0 in Q1 2021 and a floor of $197.0 in Q3 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $1057.0 (2022), compared with a mean of $56490.2.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 99.88% in 2022 and later surged 131054.31% in 2024.
  • Tenon Medical's Shares Outstanding (Weighted Average) stood at $903.0 in 2021, then decreased by 11.3% to $801.0 in 2022, then plummeted by 71.66% to $227.0 in 2023, then surged by 434.8% to $1214.0 in 2024, then soared by 508.24% to $7384.0 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $7384.0 (Q4 2025), $8250.0 (Q3 2025), and $7591.0 (Q2 2025) per Business Quant data.